Research Project

DATA-INDUCTOR brings together a network of experts in the field of safety and efficacy testing, model development and genetic immune-oncology to develop the needed preclinical tools for pharma companies. DATA-INDUCTOR consortium will support the design, production and testing of biological drugs using immunologically relevant human-based models. We will implement ISO standardized solutions to achieve GLP level safety/efficacy testing for selected assays and tools. Data-driven predictive computational models will be developed to enable prediction of drug responses and identification of novel targets. These will enable faster and more efficient translation of preclinical findings into clinical success. DATA-INDUCTOR is part of Orion’s Veturi ecosystem activities (WP1 and WP2), as one of the key actions to improve the research ecosystem capabilities in Finland. Consortium is also part of HEALTH 360 Finland.

Upcoming events

Read more

News

5.3.2026

Armored NK Cell Therapies Gain Global Momentum

The global field of cell and gene therapy is rapidly evolving toward next-generation “armored” immune cell therapies designed to overcome tumor-mediated immunosuppression. A recent example is…